| Literature DB >> 35201337 |
Jonathan Li1,2, Hao Zhou3, Max Feinstein1, Jessica Wong1, Ruikang K Wang3, Lawrence Chan1, Yining Dai3, Travis Porco1,4, Jacque L Duncan1, Daniel M Schwartz1.
Abstract
PURPOSE: Myopic macular degeneration (MMD) can cause irreversible vision loss. Thinner choroid is associated with increased MMD severity. This cross-sectional study analyzed choriocapillaris (CC) alterations in MMD.Entities:
Mesh:
Year: 2022 PMID: 35201337 PMCID: PMC8883151 DOI: 10.1167/tvst.11.2.37
Source DB: PubMed Journal: Transl Vis Sci Technol ISSN: 2164-2591 Impact factor: 3.048
Figure 1.Methodology for generating OCTA A-scan intensity profiles from OCT B-scans. (A) BM segmentation (yellow line) on a representative OCT B-scan. (B) BM segmentation (yellow line) superimposed on the corresponding OCTA B-scan. (C) The OCTA B-scan was flattened at Bruch's membrane (BM; yellow line). (D) En face view of the moving window of a selected subfield of 19 × 19 pixels on an OCTA en face image. (E) Side view of the moving window of a selected subfield of 19 × 19 pixels on an OCTA B-scan. (F) A representative OCTA A-scan intensity profile generated by averaging the OCTA signals along depth within the selected subfield. Peak of CC (arrow) was identified as the first peak beneath BM.
Figure 2.Representative OCTA A-scan intensity profiles with CC peak denoted in a normal control and MDCA patient. PCC, choriocapillaris peak.
Figure 3.Representative CC flow deficit calculation in a normal control and MDCA patient. (A, D) En face OCTA image of retina. (B, E) En face OCTA image of CC. (C, F) En face OCTA image of CC overlaid with CC FD (red) and retinal vessels (yellow) in a normal eye and a MDCA eye, respectively.
Characteristics of Eyes With Macular Diffuse Chorioretinal Atrophy Versus Controls
| Characteristic | Macular Diffuse Chorioretinal Atrophy | Controls |
|---|---|---|
| Eyes, | 16 (24) | 51 (76) |
| Subjects, | 11 (19) | 47 (81) |
| BCVA (logMAR), mean ± SD | 0.08 ± 0.11 | 0.00 ± 0.03 |
| Age at examination (yr) | ||
| Mean ± SD | 65.7 ± 12.8 | 55.6 ± 23.3 |
| Median (min, max) | 70.0 (40.0, 78.0) | 52.0 (19.0, 88.0) |
| Female gender, | 10 (91) | 26 (51) |
| Axial length (mm) | ||
| Mean ± SD | 29.67 ± 2.04 | 23.87 ± 1.04 |
| Median (min, max) | 29.63 (26.96, 33.93) | 23.63 (21.65, 25.84) |
Univariate and Multivariate Regression Modeling of Association of Risk Factors With Choriocapillaris Thickness
| Regression Beta Coefficient (95% CI) | ||
|---|---|---|
| Risk Factor | Univariate | Multivariate |
| Age | −0.053 (−0.059 to −0.047); | −0.018 (−0.037 to 0.0003); |
| Gender | ||
| Female | Reference | Reference |
| Male | 2.62 (2.35 to 2.89); | −0.28 (−1.17 to 0.60); |
| AL | −1.32 (−1.35 to −1.29); | 0.16 (−0.18 to 0.51); |
| Patient type | ||
| Control | Reference | Reference |
| MDCA | −10.18 (−10.31 to −10.05); | −10.95 (−13.33 to −8.58); |
Univariate and Multivariate Regression Modeling of Association of Risk Factors with Choriocapillaris Flow Deficit Percent
| Regression Beta Coefficient (95% CI) | ||
|---|---|---|
| Risk Factor | Univariate | Multivariate |
| Age | 0.0017 (0.0016 to 0.0018); | 0.0014 (0.0009 to 0.0018); |
| Gender | ||
| Female | Reference | — |
| Male | −0.04 (−0.08 to 0.01); | — |
| AL | 0.021 (0.020 to 0.022); | 0.006 (−0.002 to 0.014); |
| Patient type | ||
| Control | Reference | Reference |
| MDCA | 0.16 (0.15 to 0.16); | 0.11 (0.05 to 0.16); |
Choriocapillaris Parameters in Eyes With Macular Diffuse Chorioretinal Atrophy Versus Controls
| Parameter | Macular Diffuse Chorioretinal Atrophy | Controls |
|---|---|---|
| Choriocapillaris thickness (µm) | ||
| Mean ± SD | 5.23 ± 0.68 | 15.46 ± 1.82 |
| Median (min, max) | 4.92 (4.41, 6.58) | 14.81 (13.17, 20.06) |
| Choriocapillaris flow deficit (%) | ||
| Mean ± SD | 26.5 ± 4.3 | 11.2 ± 4.6 |
| Median (min, max) | 25.7 (20.0, 36.0) | 10.7 (3.8, 21.3) |